Search Results - "Tomazos, I." :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Predictors of Loss of Ambulation in Duchenne Muscular Dystrophy: A Systematic Review and Meta-Analysis

Predictors of Loss of Ambulation in Duchenne Muscular Dystrophy: A Systematic Review and Meta-Analysis

by Landfeldt, E, Alemán, A, Abner, S, Zhang, R, Werner, C, Tomazos, I, Ferizovic, N, Lochmüller, H, Kirschner, J
Published in Journal of neuromuscular diseases (01.01.2024)

Get more information

Journal Article

Factors Associated with Respiratory Health and Function in Duchenne Muscular Dystrophy: A Systematic Review and Evidence Grading

Factors Associated with Respiratory Health and Function in Duchenne Muscular Dystrophy: A Systematic Review and Evidence Grading

by Landfeldt, E, Aleman, A, Abner, S, Zhang, R, Werner, C, Tomazos, I, Lochmüller, H, Quinlivan, R M
Published in Journal of neuromuscular diseases (01.01.2024)

Get more information

Journal Article

PB1934: REAL‐WORLD OUTCOMES OF ECULIZUMAB TREATMENT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINUREA: A SYSTEMATIC LITERATURE REVIEW AND EVIDENCE SYNTHESIS

PB1934: REAL‐WORLD OUTCOMES OF ECULIZUMAB TREATMENT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINUREA: A SYSTEMATIC LITERATURE REVIEW AND EVIDENCE SYNTHESIS

by Nishimura, J.‐I., Popoff, E., Cheung, A., Wang, A., Tomazos, I., Szer, J.
Published in HemaSphere (23.06.2022)

Get full text

Journal Article

Low Rate of Clinically Evident Extravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with a Complement C5 Inhibitor: Results from a Large, Multicenter, US Real-World Study

Low Rate of Clinically Evident Extravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with a Complement C5 Inhibitor: Results from a Large, Multicenter, US Real-World Study

by Shammo, Jamile, Gajra, Ajeet, Patel, Yogesh, Tomazos, Ioannis, Kish, Jonathan, Hill, Anita, Sierra, J. Rafael, Araten, David
Published in Journal of blood medicine (01.01.2022)

Get full text

Journal Article

P813: EFFICACY, TREATMENT ADMINISTRATION SATISFACTION AND SAFETY OF SUBCUTANEOUS RAVULIZUMAB THROUGH 1 YEAR IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA WHO RECEIVED PRIOR INTRAVENOUS ECULIZUMAB

P813: EFFICACY, TREATMENT ADMINISTRATION SATISFACTION AND SAFETY OF SUBCUTANEOUS RAVULIZUMAB THROUGH 1 YEAR IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA WHO RECEIVED PRIOR INTRAVENOUS ECULIZUMAB

by Yenerel, M. N., Sicre de Fontbrune, F., Piatek, C., Sahin, F., Füreder, W., Ogawa, M., Tomazos, I., Doll, H., Ozol-Godfrey, A., Sierra, J. R., Szer, J.
Published in HemaSphere (23.06.2022)

Get full text

Journal Article

PRO77 Preliminary Characterization of Eculizumab Treatment Patterns, Preceding Disease Triggers and Supportive Therapies in Atypical Hemolytic Uremic Syndrome: A US Claims Database Analysis

PRO77 Preliminary Characterization of Eculizumab Treatment Patterns, Preceding Disease Triggers and Supportive Therapies in Atypical Hemolytic Uremic Syndrome: A US Claims Database Analysis

by Tomazos, I., Levy, A., Faria, C.
Published in Value in health (01.06.2021)

Get full text

Journal Article

PRO33 Ravulizumab Reduces Productivity Losses Versus Eculizumab for Treating Atypical Hemolytic Uremic Syndrome: A 'cost Consequence' Analysis in 4 Countries

PRO33 Ravulizumab Reduces Productivity Losses Versus Eculizumab for Treating Atypical Hemolytic Uremic Syndrome: A 'cost Consequence' Analysis in 4 Countries

by Levy, A., Chen, P., Tomazos, I.
Published in Value in health (01.12.2020)

Get full text

Journal Article

PRO5 COMPARING PRODUCTIVITY LOSSES FROM TREATING ATYPICAL HEMOLYTIC UREMIC SYNDROME PATIENTS IN THE UNITED STATES WITH ECULIZUMAB OR RAVULIZUMAB IN AN INFUSION CLINIC OR AT HOME

PRO5 COMPARING PRODUCTIVITY LOSSES FROM TREATING ATYPICAL HEMOLYTIC UREMIC SYNDROME PATIENTS IN THE UNITED STATES WITH ECULIZUMAB OR RAVULIZUMAB IN AN INFUSION CLINIC OR AT HOME

by Levy, A., Chen, P.G.F., Tomazos, I.
Published in Value in health (01.11.2019)

Get full text

Journal Article

PCR238 Estimating Health State Utilities (HSUS) for Aromatic L-Amino Acid Decarboxylase Deficiency (AADCD) in the United States

PCR238 Estimating Health State Utilities (HSUS) for Aromatic L-Amino Acid Decarboxylase Deficiency (AADCD) in the United States

by Monteleone, B, Zhang, R, Forster, K, Chua, GN, Lloyd, A, Castellano, P, Tomazos, I
Published in Value in health (01.06.2024)

Get full text

Journal Article

CO160 Relationship between Loss of Ambulation (LoA), Disease Burden, and Physical Functioning Among Boys with Duchenne Muscular Dystrophy (DMD)

CO160 Relationship between Loss of Ambulation (LoA), Disease Burden, and Physical Functioning Among Boys with Duchenne Muscular Dystrophy (DMD)

by Gordish-Dressman, H.., Zhang, R., Kamstra, R., Werner, C., Liu, E., Morrison, K., Tomazos, I.
Published in Value in health (01.06.2024)

Get full text

Journal Article

CO120 Progression of Disease Burden Among Boys with Duchenne Muscular Dystrophy (DMD) According to Ambulatory Status and Age at Loss of Ambulation (LoA)

CO120 Progression of Disease Burden Among Boys with Duchenne Muscular Dystrophy (DMD) According to Ambulatory Status and Age at Loss of Ambulation (LoA)

by Gordish-Dressman, H.., Zhang, R., Kamstra, R., Werner, C., Liu, E., Morrison, K., Tomazos, I.
Published in Value in health (01.06.2024)

Get full text

Journal Article

CO202 Relationship between Loss of Ambulation (LoA) and Timing of Pulmonary Outcomes Among Boys with Duchenne Muscular Dystrophy (DMD)

CO202 Relationship between Loss of Ambulation (LoA) and Timing of Pulmonary Outcomes Among Boys with Duchenne Muscular Dystrophy (DMD)

by Gordish-Dressman, H.., Zhang, R., Kamstra, R., Werner, C., Morrison, K., Tomazos, I.
Published in Value in health (01.06.2024)

Get full text

Journal Article

CO142 A Retrospective Study Characterizing Age at Key Clinical Disease Indicators Among Patients With Friedreich Ataxia Using Health Administrative Claims Data in the United States

CO142 A Retrospective Study Characterizing Age at Key Clinical Disease Indicators Among Patients With Friedreich Ataxia Using Health Administrative Claims Data in the United States

by Salvucci, A., Qian, C., Powell, L., Lynch, D., Vasco, G., Johnston, K., Tomazos, I.
Published in Value in health (01.12.2023)

Get full text

Journal Article

CO105 A Retrospective Study Characterizing Age at Loss of Ambulation Among Patients With Friedreich Ataxia Using Health Administrative Claims Data in the United States

CO105 A Retrospective Study Characterizing Age at Loss of Ambulation Among Patients With Friedreich Ataxia Using Health Administrative Claims Data in the United States

by Salvucci, A., Qian, C., Powell, L., Lynch, D., Vasco, G., Johnston, K., Tomazos, I.
Published in Value in health (01.12.2023)

Get full text

Journal Article

PCR139 'We Have Conversations That Other Couples Don′t Have to Have:' A Qualitative Study of the Impact of Caregiving in Friedreich Ataxia (FA)

PCR139 'We Have Conversations That Other Couples Don′t Have to Have:' A Qualitative Study of the Impact of Caregiving in Friedreich Ataxia (FA)

by Szabo, S., Bever, A., Lynch, D., Vasco, G., Giunti, P., Vallortigara, J., Tomazos, I.
Published in Value in health (01.12.2023)

Get full text

Journal Article

PCR84 The Daily Life and Psychosocial Impacts of Friedreich Ataxia: A Qualitative Study of Patient Lived Experiences

PCR84 The Daily Life and Psychosocial Impacts of Friedreich Ataxia: A Qualitative Study of Patient Lived Experiences

by Bever, A., Szabo, S., Vallortigara, J., Giunti, P., Lynch, D., Vasco, G., Tomazos, I.
Published in Value in health (01.12.2023)

Get full text

Journal Article

RWD59 Association of Time of Loss of Ambulation with Severity of Respiratory Symptoms in Patients with Nonsense Mutation Duchenne Muscular Dystrophy (NMDMD)

RWD59 Association of Time of Loss of Ambulation with Severity of Respiratory Symptoms in Patients with Nonsense Mutation Duchenne Muscular Dystrophy (NMDMD)

by Tulinius, M., Zhang, R., Lee, B., Madin-Warburton, M., Werner, C., Tomazos, I.
Published in Value in health (01.06.2023)

Get full text

Journal Article

SA70 Patient-Reported Outcomes and Daily Activity Assessed with a Digital Wearable Device (FITBIT™) in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Ravulizumab: The Reveal Study

SA70 Patient-Reported Outcomes and Daily Activity Assessed with a Digital Wearable Device (FITBIT™) in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Ravulizumab: The Reveal Study

by Griffiths, E.A, Wang, A., Tomazos, I., Min, J.S, Lee, W.N, Patel, Y., Yu, J., Dingli, D.
Published in Value in health (01.06.2023)

Get full text

Journal Article

RWD128 A Retrospective Claims Analysis Characterizing Health Care Resource Use Among Patients with Friedreich Ataxia in the United States

RWD128 A Retrospective Claims Analysis Characterizing Health Care Resource Use Among Patients with Friedreich Ataxia in the United States

by Qian, C., Lynch, D., Powell, L., Salvucci, A., Vasco, G., Johnston, K.M, Tomazos, I.
Published in Value in health (01.06.2023)

Get full text

Journal Article

RWD99 The Clinical Burden of Friedreich Ataxia: A Retrospective Claims Analysis in the United States

RWD99 The Clinical Burden of Friedreich Ataxia: A Retrospective Claims Analysis in the United States

by Powell, L., Lynch, D., Qian, C., Salvucci, A., Vasco, G., Johnston, K.M, Tomazos, I.
Published in Value in health (01.06.2023)

Get full text

Journal Article